Abstract
Melanoma, the most aggressive form of skin cancer, is often fatal if not treated early. Therefore, novel target-based strategies are required to combat this neoplasm. The objective of this study was to determine the role and functional significance of the mitochondrial sirtuin 3 (SIRT3) in melanoma. We found that compared with normal primary and immortalized human melanocytes, SIRT3 is significantly overexpressed in multiple human melanoma cells at mRNA and protein levels. Further, employing human tissue microarray, we found that SIRT3 is significantly upregulated in clinical melanoma tissues, compared with melanocytic nevi tissues. Furthermore, a short hairpin RNA-mediated knockdown of SIRT3 in human melanoma cells resulted in (i) a decrease in cellular proliferation, colony formation, and cellular migration; (ii) induction of senescence as shown by an increase in senescence-associated beta-galactosidase activity and formation of senescence-associated heterochromatin foci as well as an increase in mRNA and protein levels of p16INK4a and p21Waf1; (iii) G1-phase arrest of the cell cycle; and (iv) decreases in mRNA and protein levels of cyclins (D1, E1) and cyclin-dependent kinases (2, 4, and 6). Conversely, forced exogenous overexpression of SIRT3 promoted an increase in proliferative potential of Hs294T melanoma cells and normal immortalized Mel-ST melanocytes. Finally, we found that SIRT3 knockdown significantly inhibited tumorigenesis in a xenograft model in vivo. To our knowledge, this is the first study supporting the pro-proliferative function of SIRT3 in melanoma.
Original language | English |
---|---|
Pages (from-to) | 809-818 |
Number of pages | 10 |
Journal | Journal of Investigative Dermatology |
Volume | 136 |
Issue number | 4 |
DOIs | |
State | Published - 2016 |
Bibliographical note
Publisher Copyright:© 2015 The Authors
Funding
We thank Dr Robert Weinberg (Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA) for kindly providing Mel-ST cells used in this study. We are also thankful to Mary Ndiyae for technical assistance in melanoma cell implantation in Nu/Nu mice. This work was partially supported by funding from the NIH (R01AR059130, R01CA176748) and the Department of Veterans Affairs (VA Merit Review Award 1I01BX001008).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | R01CA192894, R01AR059130, R01CA176748 |
National Childhood Cancer Registry – National Cancer Institute | K01CA114401 |
U.S. Department of Veterans Affairs | 1I01BX001008 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Dermatology
- Cell Biology